AstraZeneca
AZN
#64
Rank
A$351.86 B
Marketcap
A$226.88
Share price
-1.18%
Change (1 day)
-1.82%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): A$10.53

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is A$9.74. In 2024 the company made an earnings per share (EPS) of A$6.36 an increase over its 2023 EPS that were of A$5.38.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$10.53
2024A$6.3618.23%
2023A$5.3881.13%
2022A$2.97631.03%
2021A$0.41-88.11%
2020A$3.42136.89%
2019A$1.44-39.41%
2018A$2.38-28.27%
2017A$3.32-14.37%
2016A$3.8824.11%
2015A$3.13127.55%
2014A$1.37-51.96%
2013A$2.86-58.95%
2012A$6.97-32.2%
2011A$10.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.24 25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.84 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.84-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.06-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$39.57 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.59-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$13.11 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.01-48.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.99-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.45-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK